|
 |
| home > epc > Winter 2002 |
|
|
 PUBLICATIONS |
European Pharmaceutical Contractor |
|
|
|
|
| At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. EPC provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of EPC |
 |
| |
|
|
| In his Editor's Letter, Dr Graham Hughes reviews the articles in this Winter issue of EPC |
|
|
|
|
| Until recently the idea of outsourcing pharmacovigilance activities fell outside the comfort zone of all but a few pharmaceutical companies. Liz Nowell, Pharmacovigilance Manager, Alan Rawling, Managing Director of Assured Information Systems and Dr Michael Bowden, Managing Director of the European Division, Health Decisions, discuss this new approach, in Meeting new Pharmacovigilance Challenges - the Need for Outsourcing |
|
|
| In The Ethics of Research Related to Health Care in Developing Countries - Implications of the Report for the Pharmaceutical Industry, Professor Sir Kenneth Calman, Vice-Chancellor and Warden at the University of Durham, highlights the need to continue supporting future research as outlined in a report by the Nuffield Council on Bioethics |
|
|
| John A Morris, Head of European Pharmaceuticals at KPMG, comments on recent developments threatening to wrest control of pricing further from the hands of pharmaceutical companies, in Pharma Companies Are Losing Control of Pricing |
|
|
|
| Chris Tait, Head of Chubb Insurance, comments that careful risk management can minimise the potential for litigation, in Clinical Trials: Loss Prevention is Better Than Cure |
|
|
| Parallel initiatives introduced in the US in the late 1990s have led to unprecedented growth in the field of paediatric clinical trials. Simon Robinson, Programme Director, International Paediatrics at Intercern, analyses this trend, in Paediatric Clinical Trials - Implications for Contractors |
|
|
|
|
| Co-promotions often amply reward the participants and allow for collaborations that might not otherwise be consummated. In Prescription Drug Co-Promotion: 21st Century Dealmaking, David Schulman, David Wallis and Helen Hunsperger at International Law Firm Dechert, explore drug co-promotion activity |
|
|
| In Managing Tax Payment - How to Avoid Paying Tax at 60 Per Cent or More, Andrew Hickman, European Regional Co-ordinator, and Emma Cuthbertson, Senior Manager in KPMG's London-based Global Transfer Pricing Services group, warn of the risk of double taxation and advise on how that risk can be managed |
|
|
|
|
| Dr Graham Bunn, Global Vice-President of e-Clinical Business at Quintiles, investigates the complexity, regulation, process inertia and employee resistance to EDC scale-up, in The Great Escape - From EDC Pilot to Full Scale Implementation |
|
|
| In In or Out? - IT Outsourcing Options for Pharmaceutical Companies, Nick Robinson, CEO of Phoenix IT Services, outlines the need to exploit all market opportunities and suggests that much can be gained from managed services, ASP and outsourcing relationships |
|
|
|
| In The Outlook for Central Nervous System Drug Development, Dr Faiz Kermani, Budgets, Proposals and Marketing Executive, and Stuart McGuire, Business Development Executive at Chiltern International examine the progress in developing new treatments for these complex disorders |
|
|
| Traditionally, sponsors have included feasibility checks in the process of choosing a study site. In Assessing Study Feasibility in the Netherlands - A Research Site's Point of View, Dr Henk Mulder, Director of Osteosupport BV, outlines a sponsor's key considerations for validation of a research site |
|
|
|
|
| John Butterworth, Director of Clinical Trials Network at TNT Express, discusses the concept of providing a complete palette of logistics services to support clinical trials, in Improving Clinical Trial Logistics - A Courier's Perspective |
|
|
| In Pharma Companies Must Jump on the Brand Wagon, Stephanie Loeffler, Partner at Marks & Clerk, considers the need for brand equity to be established and protected from the outset if it is to be profitable |
|
|
| Richard Perkes, Technical Director at Cool Logistics, provides an overview of the direction in which the distribution industry is developing and outlines the options available for companies requiring improved performance from their temperature controlled packaging, in The Growing Importance of Cold Chain Distribution in the Pharmaceutical and Biotechnology Industries |
|
|
|
| Biotechnology, especially its pharmaceutical sector, is regarded as one of the most promising areas of industry. In Biotechnology - A Challenge for Young Companies and Old Regulators, Pekka Kurki, MD, PhD, Senior Medical Officer at the Department of Pharmacology, National Agency for Medicines, Finland, analyses the challenges posed for industry |
|
|
| In EDC Use in Clinical Trials: Are we on the Verge of a Breakthrough?, Mike Miller-Smith, Marketing Manager at CRF Box, raises important issues vital to the successful widespread adoption of electronic data capture (EDC) based on experiences gained both from a pharmaceutical company and vendor perspective |
|
|
| Rainer Hilli, Partner and Tom Groop, Associate of Roschier Holmberg Attorneys Ltd, examine the Finnish Government's suggested procedure for generic substitution, in Generic Substitution - The Proposed Procedure for the Prescription of Pharmaceuticals in Finland |
|
|
|
| For many years now, there has been centralisation of laboratory analysis for particular aspects of clinical trials. In Rationalised Analytical Laboratory Services for Tomorrow's Clinical Trials, John L Allinson, Laboratory Director of BAS Analytics in the UK, examines the potential for the bioanalytical and central laboratory to form a much closer working relationship |
|
|
| Pharmaceutical and biotechnology companies have one thing in common: they rely on high quality laboratory results in order to evaluate the efficacy of their drugs. Dr Hermann Schulz, President and Co-Founder of INTERLAB GmbH, discusses this need, in Centralised Laboratory Testing for Clinical Trials: The Advantages of Using a Global Specialist |
|
|
|
| Rome, 'The Eternal City', will host the 15th Annual DIA EuroMeeting in March 2003. In a preview, The Drug Information Association outlines the agenda and programme news for the event to be held this coming spring |
|
|
| InfoTechPharma is the unique world meeting place for information technology specialists and R&D professionals working in the pharmaceutical and biotechnology industries. In InfoTechPharma 2003, The 7th Annual Conference and Free Exhibition, event organisers IBC Life Sciences inform us of what's in store |
|
|
|
|
|
 |
|
|
 |
Industry Events |
 |
ICSE South America
17-19 August 2010, Buenos Aires, Argentina
ICSE is the international stage for companies providing outsourcing services in clinical trials, contract research, custom manufacturing, biotechnology, IT, analytical services, packaging services and logistics. The first ICSE SA event was launched in 2008. For years ICSE has been connecting buyers and sellers in the market of (bio)pharmaceutical and pharma-related contract services. ICSE SA is a Pavilion within CPhI SA.
More info >> |
|
 |
News and Press Releases |
 |
PharmaBrand Summit 2010
Top pharmaceutical executives shared best practices at the PharmaBrand Summit
2010, which took place on the 21st to 23rd June 2010 in Monte-Carlo, Monaco
and was organised by Marcus Evans
More info >> |
|
__________________________
__________________________
__________________________
__________________________
__________________________
 |
